Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease
Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease
Not yet recruiting · NCT07118696 · Registry updated 2025-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Not yet recruiting | Phase 3 | 2025-08-12 | NCT07118696 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hamilton Health Sciences Corporation | 60 |
| McMaster University | 202 |
| St George's, University of London | 18 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||